Key result
Psychotropic medications linked to CV side effects including autonomic dysfunction, arrhythmias, and thromboembolism.
Why the study?
Psychotropic medications used in serious mental health illnesses can cause significant cardiovascular side effects, creating a pressing need for physicians to be aware of their cardiotoxicity.
Physicians must be aware of and continually monitor for cardio-toxicity, including arrhythmias and thromboembolic events, in patients receiving psychotropic pharmacotherapy.
May support monitoring for cardiotoxicity with psychotropics; leaves open incidence, mechanisms, and surveillance strategies.
Cardiovascular disease is the leading cause of death in people with serious mental health illnesses, including schizophrenia, major depression and bipolar disorder. The adverse cardiac risk profile of this population is related to the complex interplay between biological, patient-specific and healthcare system factors. A variety of psychotropic medications used to treat these conditions can in themselves produce cardiovascular side effects. This includes autonomic dysfunction, malignant ventricular arrhythmias, heart muscle disorders and vascular thromboembolic events, some of which have been linked with sudden cardiac death. As a result, there is a pressing need for physicians to be aware of the cardio-toxicity associated with psychotropic medication use. In this review, we summarise the main effects of psychotropic drugs on the cardiovascular system and the current recommendations for evaluation and continual monitoring of the many and rapidly increasing number of patients receiving psychotropic pharmacotherapy.
No takes yet. Share an insight, caveat, or question.
Androshchuk et al. (2025) conducted a review in Serious mental health illnesses (schizophrenia, major depression, bipolar disorder). Psychotropic medications was evaluated on Cardiovascular side effects. Psychotropic medications can produce cardiovascular side effects such as autonomic dysfunction, malignant ventricular arrhythmias, heart muscle disorders, and vascular thromboembolic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: